Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023) [Yahoo! Finance]
Personalis, Inc. (PSNL)
Last personalis, inc. earnings: 3/25 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Net loss: US$13.0m (loss narrowed by 55% from 1Q 2023). US$0.26 loss per share (improved from US$0.61 loss in 1Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Personalis Earnings Insights Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Life Sciences industry in the US. Performance of the American Life Sciences industry. The company's shares are down 2.2% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Personalis that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not
Show less
Read more
Impact Snapshot
Event Time:
PSNL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSNL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSNL alerts
High impacting Personalis, Inc. news events
Weekly update
A roundup of the hottest topics
PSNL
News
- New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse [Yahoo! Finance]Yahoo! Finance
- Tempus Announces the Clinical Launch of its MRD Testing Portfolio [Yahoo! Finance]Yahoo! Finance
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus [Yahoo! Finance]Yahoo! Finance
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusBusiness Wire
- Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024 [Yahoo! Finance]Yahoo! Finance
PSNL
Earnings
- 5/8/24 - Beat
PSNL
Sec Filings
- 5/21/24 - Form 4
- 5/21/24 - Form 4
- 5/21/24 - Form 4
- PSNL's page on the SEC website